DMD and Becker muscular dystrophy: Levels of (lifelong expression of) dystrophin in Becker muscular dystrophy (BMD) patients have been reported to vary between 10 and 90%, with a mean of 33% [13,14], but these may not be easily obtainable when starting therapies targeting dystrophic muscle tissue later in life.